Thrombosis
Conference Coverage
Cost is the main hurdle to broad use of caplacizumab for TTP
“If we take finances out, I think almost every patient except those with a bleeding risk or bleeding problem should get it,” an investigator said...
Conference Coverage
No benefit from tranexamic acid prophylaxis in blood cancers
Conference Coverage
VTE prophylaxis is feasible, effective in some high-risk cancer patients
Conference Coverage
What to do when anticoagulation fails cancer patients
Conference Coverage
Liver injury linked to COVID-19–related coagulopathy
Cells that line the liver’s blood vessels produce high levels of factor VIII, a coagulation factor, when they are exposed to interleukin-6, an...
Conference Coverage
Factor XI inhibitor–based anticoagulation strategies gain ground
“When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”
Conference Coverage
VTEs tied to immune checkpoint inhibitor cancer treatment
Retrospective analysis hints that cancer patients have an elevated risk for venous thromboembolism following treatment with an immune checkpoint...
From the Journals
Proinflammatory dietary pattern linked to higher CV risk
Diets high in foods that increase inflammation were associated with increased risk of heart disease and stroke, compared with those filled with...
Conference Coverage
Warfarin use linked to knee and hip replacement in osteoarthritis patients
Results of a large nested, case-control study provide further evidence of the role of vitamin K in reducing osteoarthritis progression,...
Conference Coverage
COMPARE CRUSH: Crushed prehospital prasugrel misses mark in STEMI
The findings add to earlier work suggesting no safety issues when giving crushed P2Y12 inhibitor tablets in the ambulance, but also no clear...
From the Journals
COVID-19: Thromboembolic events high despite prophylaxis
“Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight...